Single-agent thalidomide for treatment of first relapse following high-dose chemotherapy in patients with multiple myeloma

被引：3
|
作者：
Fenk, R
Hoyer, B
Steidl, U
Kondakci, M
Graef, T
Heuk, R
Ruf, L
Strupp, C
Neumann, F
Rohr, UP
Hildebrandt, B
Haas, R
Kobbe, G
机构：
[1] Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, D-40225 Dusseldorf, Germany
[2] Harvard Univ, Inst Med, Div Hematol Oncol, Boston, MA 02115 USA
[3] Univ Dusseldorf, Dept Human Genet & Anthropol, D-40225 Dusseldorf, Germany
来源：
LEUKEMIA | 2005年 / 19卷 / 01期
关键词：
D O I：
10.1038/sj.leu.2403564
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：156 / 159
页数：5
相关论文
共 50 条
  • [41] Biochemical markers of bone turnover following high-dose chemotherapy and autografting in multiple myeloma
    Clark, RE
    Flory, AJ
    Ion, EM
    Woodcock, BE
    Durham, BH
    Fraser, WD
    BLOOD, 2000, 96 (08) : 2697 - 2702
  • [42] High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy
    Bierman, PJ
    Anderson, JR
    Freeman, MB
    Vose, JM
    Kessinger, A
    Bishop, MR
    Armitage, JO
    ANNALS OF ONCOLOGY, 1996, 7 (02) : 151 - 156
  • [43] HEMOSTASIS IN PATIENTS WITH MULTIPLE MYELOMA BEFORE AND DURING HIGH-DOSE CHEMOTHERAPY.
    Urnova, E.
    Pokrovskaya, O.
    Mendeleeva, L.
    Gracheva, M.
    Balandina, A.
    Vasiliev, S.
    Ataullakhanov, F.
    Savchenko, V.
    HAEMATOLOGICA, 2013, 98 : 612 - 612
  • [44] High-dose melphalan in patients with multiple myeloma
    Moreau, P
    Le Bonniec, M
    Harousseau, JL
    BULLETIN DU CANCER, 1999, 86 (03) : 283 - 288
  • [45] Daily low dose thalidomide plus monthly high-dose dexamethasone as consolidation/maintenance treatment in elderly multiple myeloma (MM) patients
    Vigna, E.
    Mazzone, C.
    Gentile, M.
    Lucia, E.
    Iorio, C.
    Morelli, R.
    Bisconte, M. G.
    Gentile, C.
    Morabito, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 143 - 143
  • [46] SINGLE-AGENT ACTIVITY OF HIGH-DOSE METHOTREXATE WITH CITROVORUM FACTOR RESCUE
    VONHOFF, DD
    ROZENCWEIG, M
    LOUIE, AC
    BENDER, RA
    MUGGIA, FM
    CANCER TREATMENT REPORTS, 1978, 62 (02): : 233 - 235
  • [47] STUDIES OF HIGH-DOSE CHEMOTHERAPY IN MULTIPLE-MYELOMA (MM)
    PERREN, TJ
    SELBY, PJ
    MBIDDE, RK
    MALPAS, JS
    MCELWAIN, TJ
    BRITISH JOURNAL OF CANCER, 1986, 54 (01) : 207 - 207
  • [48] Single-agent paclitaxel in patients with metastatic breast cancer receiving high-dose chemotherapy with peripheral blood stem cell support
    Schwartzberg, LS
    Weaver, CH
    Birch, R
    Giudice, R
    Sobong, E
    Schnell, F
    Kalman, L
    Buckner, CD
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (02): : 162 - 167
  • [49] Minimal residual disease status is the prognostic determinant following high-dose treatment for patients with multiple myeloma
    Nahi, Hareth
    Afram, Gabriel
    Uttervall, Katarina
    Lockmer, Sandra
    Tatting, Love
    Gahrton, Gosta
    Kashif, Muhammad
    Alici, Evren
    Stromberg, Olga
    Klimkowska, Monika
    Lund, Johan
    CANCER MEDICINE, 2023, 12 (22): : 20736 - 20744
  • [50] Single dose pharmacokinetic study of thalidomide in patients with multiple myeloma.
    Pathak, A.
    Malhotra, J.
    Raina, V
    Arya, D. S.
    Gupta, Y. K.
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 218 - 218
12345